Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction

被引:201
|
作者
Perrino, Cinzia
Prasad, Sathyamangla V. Naga
Mao, Lan
Noma, Takahisa
Yan, Zhen
Kim, Hyung-Suk
Smithies, Oliver
Rockman, Howard A.
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2006年 / 116卷 / 06期
关键词
D O I
10.1172/JCI25397
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered beta-adrenergic receptor (beta AR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by beta AR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.
引用
收藏
页码:1547 / 1560
页数:14
相关论文
共 50 条
  • [41] ENALAPRILAT DECREASES ISCHEMIC DIASTOLIC DYSFUNCTION IN PRESSURE OVERLOAD HYPERTROPHY
    EBERLI, FR
    APSTEIN, CS
    NGOY, S
    LORELL, BH
    CIRCULATION, 1990, 82 (04) : 161 - 161
  • [42] Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway
    Hsu, Steven
    Nagayama, Takahiro
    Koitabashi, Norimichi
    Zhang, Manling
    Zhou, Liye
    Bedja, Djahida
    Gabrielson, Kathleen L.
    Molkentin, Jeffery D.
    Kass, David A.
    Takimoto, Eiki
    CARDIOVASCULAR RESEARCH, 2009, 81 (02) : 301 - 309
  • [43] Triheptanoin diet alleviates hypertrophy and diastolic dysfunction and preserves cardiac glucose oxidation in rats with pressure overload
    Nguyen, T. D.
    Shingu, Y.
    Amorim, P. A.
    Schwarzer, M.
    Doenst, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S72 - S72
  • [44] A high fat diet, but not a high sucrose diet, prevents pressure overload induced cardiac dysfunction and hypertrophy
    Duda, Monika Katarzyna
    O'Shea, Karen M.
    McElfresh, Tracy A.
    Hoit, Brian D.
    Stanley, William C.
    FASEB JOURNAL, 2007, 21 (06): : A1254 - A1255
  • [45] Beneficial effect of eNOS overexpression on pressure overload induced cardiac hypertrophy and dysfunction unmasked by ROS scavenging
    van Deel, Elza Dianne
    de Boer, Martine
    Merkus, Daphne
    van Haperen, Rien
    de Crom, Rini
    Duncker, Dirk Jan
    FASEB JOURNAL, 2011, 25
  • [46] Systemic Loss of p62 Reduces Pressure Overload Induced Cardiac Hypertrophy, Dysfunction and Apoptosis
    Auger-Messier, Mannix
    Rezvani, Khosrow
    Pattison, Scott
    CIRCULATION RESEARCH, 2016, 119
  • [47] Genetic deletion of CXCL10 prevents pressure overload-induced cardiac hypertrophy and dysfunction
    Souza-Neto, Fernando
    van Berlo, Jop H.
    PHYSIOLOGY, 2023, 38
  • [48] Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
    Zhou, Heng
    Shen, Di-Fei
    Bian, Zhou-Yan
    Zong, Jing
    Deng, Wei
    Zhang, Yan
    Guo, Yuan-Yuan
    Li, Hongliang
    Tang, Qi-Zhu
    PLOS ONE, 2011, 6 (10):
  • [49] Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice
    Zou, Yunzeng
    Lin, Li
    Ye, Yong
    Wei, Jianming
    Zhou, Ning
    Liang, Yanyan
    Gong, Hui
    Li, Lei
    Wu, Jian
    Li, Yunbo
    Jia, Zhenhua
    Wu, Yiling
    Zhou, Jingmin
    Ge, Junbo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (03) : 268 - 280
  • [50] A high fat diet decreases plasma insulin and prevents pressure overload induced cardiac dysfunction and hypertrophy
    O'Shea, Karen M.
    Duda, Monika K.
    McElfresh, Tracy A.
    Hoit, Brian D.
    Stanley, William C.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S64 - S64